06/01/2021 |
NICARDIPINE HYDROCHLORIDE NDA #022276 |
SUPPL-18 |
NICARDIPINE HYDROCHLORIDE |
HIKMA INTL PHARMS |
Labeling |
Approval |
06/01/2021 |
NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE NDA #022276 |
SUPPL-18 |
NICARDIPINE HYDROCHLORIDE |
HIKMA INTL PHARMS |
Labeling |
Approval |
06/01/2021 |
ALBUTEROL SULFATE ANDA #207085 |
ORIG-1 |
ALBUTEROL SULFATE |
SANDOZ |
|
Approval |
06/01/2021 |
VYNDAQEL NDA #211996 |
SUPPL-1 |
TAFAMIDIS MEGLUMINE |
FOLDRX PHARMS |
Labeling |
Approval |
06/01/2021 |
VYNDAMAX NDA #212161 |
SUPPL-1 |
TAFAMIDIS |
FOLDRX PHARMS |
Labeling |
Approval |
06/01/2021 |
LIDOCAINE HYDROCHLORIDE ANDA #212821 |
SUPPL-1 |
LIDOCAINE HYDROCHLORIDE |
HUONS |
Manufacturing (CMC) |
Approval |
06/01/2021 |
TOFACITINIB CITRATE ANDA #212943 |
ORIG-1 |
TOFACITINIB CITRATE |
AJANTA PHARMA LTD |
|
Approval |
06/01/2021 |
TOFACITINIB CITRATE ANDA #212943 |
ORIG-2 |
TOFACITINIB CITRATE |
AJANTA PHARMA LTD |
|
Tentative Approval |
06/01/2021 |
OSIMERTINIB MESYLATE ANDA #214263 |
ORIG-1 |
OSIMERTINIB MESYLATE |
ZYDUS PHARMS USA INC |
|
Tentative Approval |
06/01/2021 |
BREXAFEMME NDA #214900 |
ORIG-1 |
IBREXAFUNGERP CITRATE |
SCYNEXIS |
Type 1 - New Molecular Entity |
Approval |
06/02/2021 |
DOLOPHINE HYDROCHLORIDE NDA #006134 |
SUPPL-50 |
METHADONE HYDROCHLORIDE |
HIKMA |
Labeling |
Approval |
06/02/2021 |
METHADONE HYDROCHLORIDE NDA #017058 |
SUPPL-27 |
METHADONE HYDROCHLORIDE |
HIKMA |
Labeling |
Approval |
06/02/2021 |
METHADOSE NDA #017116 |
SUPPL-41 |
METHADONE HYDROCHLORIDE |
SPECGX LLC |
Labeling |
Approval |
06/02/2021 |
METHADONE HYDROCHLORIDE NDA #021624 |
SUPPL-14 |
METHADONE HYDROCHLORIDE |
MYLAN INSTITUTIONAL |
Labeling |
Approval |
06/02/2021 |
MORPHINE SULFATE NDA #022195 |
SUPPL-10 |
MORPHINE SULFATE |
HIKMA |
Efficacy |
Approval |
06/02/2021 |
MORPHINE SULFATE NDA #022207 |
SUPPL-5 |
MORPHINE SULFATE |
HIKMA |
Efficacy |
Approval |
06/02/2021 |
METHADONE HYDROCHLORIDE ANDA #040517 |
SUPPL-30 |
METHADONE HYDROCHLORIDE |
SPECGX LLC |
Labeling |
Approval |
06/02/2021 |
METHADONE HYDROCHLORIDE ANDA #087393 |
SUPPL-49 |
METHADONE HYDROCHLORIDE |
HIKMA |
Labeling |
Approval |
06/02/2021 |
METHADONE HYDROCHLORIDE ANDA #087997 |
SUPPL-41 |
METHADONE HYDROCHLORIDE |
HIKMA |
Labeling |
Approval |
06/02/2021 |
METHADONE HYDROCHLORIDE ANDA #088108 |
SUPPL-22 |
METHADONE HYDROCHLORIDE |
ROXANE |
Labeling |
Approval |
06/02/2021 |
METHADONE HYDROCHLORIDE ANDA #088109 |
SUPPL-21 |
METHADONE HYDROCHLORIDE |
ROXANE |
Labeling |
Approval |
06/02/2021 |
METHADONE HYDROCHLORIDE ANDA #090707 |
SUPPL-24 |
METHADONE HYDROCHLORIDE |
VISTAPHARM LLC |
Labeling |
Approval |
06/02/2021 |
RAXIBACUMAB BLA #125349 |
SUPPL-26 |
RAXIBACUMAB |
HUMAN GENOME SCIENCES INC. |
|
Approval |
06/02/2021 |
GABAPENTIN ANDA #202764 |
SUPPL-6 |
GABAPENTIN |
INVAGEN PHARMS |
Labeling |
Approval |
06/02/2021 |
GABAPENTIN ANDA #202764 |
SUPPL-7 |
GABAPENTIN |
INVAGEN PHARMS |
Labeling |
Approval |
06/02/2021 |
GABAPENTIN ANDA #202764 |
SUPPL-8 |
GABAPENTIN |
INVAGEN PHARMS |
Labeling |
Approval |
06/02/2021 |
GABAPENTIN ANDA #202764 |
SUPPL-21 |
GABAPENTIN |
INVAGEN PHARMS |
Labeling |
Approval |
06/02/2021 |
GABAPENTIN ANDA #202764 |
SUPPL-24 |
GABAPENTIN |
INVAGEN PHARMS |
Labeling |
Approval |
06/02/2021 |
GABAPENTIN ANDA #202764 |
SUPPL-25 |
GABAPENTIN |
INVAGEN PHARMS |
Labeling |
Approval |
06/02/2021 |
METHADONE HYDROCHLORIDE ANDA #203502 |
SUPPL-8 |
METHADONE HYDROCHLORIDE |
AUROLIFE PHARMA LLC |
Labeling |
Approval |
06/02/2021 |
METHADONE HYDROCHLORIDE ANDA #204166 |
SUPPL-1 |
METHADONE HYDROCHLORIDE |
VISTAPHARM LLC |
Labeling |
Approval |
06/02/2021 |
AKYNZEO NDA #205718 |
SUPPL-9 |
NETUPITANT; PALONOSETRON HYDROCHLORIDE |
HELSINN HLTHCARE |
Labeling |
Approval |
06/02/2021 |
METHADONE HYDROCHLORIDE ANDA #207537 |
SUPPL-3 |
METHADONE HYDROCHLORIDE |
SPECGX LLC |
Labeling |
Approval |
06/02/2021 |
METHADONE HYDROCHLORIDE ANDA #208305 |
SUPPL-5 |
METHADONE HYDROCHLORIDE |
SUN PHARM INDUSTRIES |
Labeling |
Approval |
06/02/2021 |
METHADONE HYDROCHLORIDE ANDA #210484 |
SUPPL-6 |
METHADONE HYDROCHLORIDE |
ELITE LABS INC |
Labeling |
Approval |
06/02/2021 |
AKYNZEO NDA #210493 |
SUPPL-4 |
FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE |
HELSINN HLTHCARE |
Labeling |
Approval |
06/02/2021 |
METHADONE HYDROCHLORIDE ANDA #211228 |
SUPPL-2 |
METHADONE HYDROCHLORIDE |
ASCENT PHARMS INC |
Labeling |
Approval |
06/02/2021 |
MICAFUNGIN SODIUM ANDA #211713 |
ORIG-1 |
MICAFUNGIN SODIUM |
XELLIA PHARMS APS |
|
Approval |
06/02/2021 |
OXYCODONE HYDROCHLORIDE ANDA #213761 |
ORIG-1 |
OXYCODONE HYDROCHLORIDE |
QUAGEN |
|
Approval |
06/02/2021 |
CHLORPROMAZINE HYDROCHLORIDE ANDA #214542 |
ORIG-1 |
CHLORPROMAZINE HYDROCHLORIDE |
GENUS |
|
Approval |
06/02/2021 |
MONJUVI BLA #761163 |
SUPPL-1 |
TAFASITAMAB-CXIX |
MORPHOSYS US INC |
|
Approval |
06/03/2021 |
BETAPACE NDA #019865 |
SUPPL-22 |
SOTALOL HYDROCHLORIDE |
LEGACY PHARMA |
Labeling |
Approval |
06/03/2021 |
TRIGLIDE NDA #021350 |
SUPPL-23 |
FENOFIBRATE |
SKYEPHARMA AG |
Labeling |
Approval |
06/03/2021 |
LIPOFEN NDA #021612 |
SUPPL-24 |
FENOFIBRATE |
CIPHER PHARMS INC |
Labeling |
Approval |
06/03/2021 |
TRICOR NDA #021656 |
SUPPL-30 |
FENOFIBRATE |
ABBVIE |
Labeling |
Approval |
06/03/2021 |
TRICOR NDA #021656 |
SUPPL-31 |
FENOFIBRATE |
ABBVIE |
Labeling |
Approval |
06/03/2021 |
ANTARA (MICRONIZED) NDA #021695 |
SUPPL-22 |
FENOFIBRATE |
LUPIN |
Labeling |
Approval |
06/03/2021 |
FENOGLIDE NDA #022118 |
SUPPL-13 |
FENOFIBRATE |
SALIX |
Labeling |
Approval |
06/03/2021 |
TRILIPIX NDA #022224 |
SUPPL-16 |
CHOLINE FENOFIBRATE |
ABBVIE |
Labeling |
Approval |
06/03/2021 |
TRILIPIX NDA #022224 |
SUPPL-17 |
CHOLINE FENOFIBRATE |
ABBVIE |
Labeling |
Approval |
06/03/2021 |
FIBRICOR NDA #022418 |
SUPPL-19 |
FENOFIBRIC ACID |
ATHENA |
Labeling |
Approval |
06/03/2021 |
DIAZEPAM ANDA #070312 |
SUPPL-17 |
DIAZEPAM |
HIKMA |
Labeling |
Approval |
06/03/2021 |
FENOFIBRATE (MICRONIZED) ANDA #075753 |
SUPPL-13 |
FENOFIBRATE |
RHODES PHARMS |
Labeling |
Approval |
06/03/2021 |
FENOFIBRATE (MICRONIZED) ANDA #075868 |
SUPPL-23 |
FENOFIBRATE |
IMPAX LABS |
Labeling |
Approval |
06/03/2021 |
FENOFIBRATE ANDA #076509 |
SUPPL-34 |
FENOFIBRATE |
IMPAX LABS |
Labeling |
Approval |
06/03/2021 |
FENOFIBRATE ANDA #076520 |
SUPPL-21 |
FENOFIBRATE |
MYLAN |
Labeling |
Approval |
06/03/2021 |
FENOFIBRATE ANDA #076635 |
SUPPL-15 |
FENOFIBRATE |
SUN PHARM INDS LTD |
Labeling |
Approval |
06/03/2021 |
FENOFIBRATE (MICRONIZED) ANDA #202676 |
SUPPL-9 |
FENOFIBRATE |
RISING |
Labeling |
Approval |
06/03/2021 |
FENOFIBRATE ANDA #204019 |
SUPPL-15 |
FENOFIBRATE |
LUPIN LTD |
Labeling |
Approval |
06/03/2021 |
FENOFIBRATE (MICRONIZED) ANDA #205566 |
SUPPL-5 |
FENOFIBRATE |
GLENMARK PHARMS LTD |
Labeling |
Approval |
06/03/2021 |
FENOFIBRATE (MICRONIZED) ANDA #207378 |
SUPPL-7 |
FENOFIBRATE |
INVAGEN PHARMS |
Labeling |
Approval |
06/03/2021 |
FENOFIBRATE (MICRONIZED) ANDA #207564 |
SUPPL-2 |
FENOFIBRATE |
NOVAST LABS |
Labeling |
Approval |
06/03/2021 |
FENOFIBRATE (MICRONIZED) ANDA #207805 |
SUPPL-16 |
FENOFIBRATE |
REYOUNG |
Labeling |
Approval |
06/03/2021 |
FENOFIBRATE ANDA #209660 |
SUPPL-3 |
FENOFIBRATE |
CHARTWELL RX |
Labeling |
Approval |
06/03/2021 |
FENOFIBRATE ANDA #209950 |
SUPPL-4 |
FENOFIBRATE |
AMNEAL |
Labeling |
Approval |
06/03/2021 |
FENOFIBRATE ANDA #210138 |
SUPPL-18 |
FENOFIBRATE |
AJANTA PHARMA LTD |
Labeling |
Approval |
06/03/2021 |
FENOFIBRATE ANDA #210606 |
SUPPL-4 |
FENOFIBRATE |
RISING PHARMA |
Labeling |
Approval |
06/03/2021 |
FENOFIBRATE ANDA #210670 |
SUPPL-4 |
FENOFIBRATE |
DR REDDYS |
Labeling |
Approval |
06/03/2021 |
FENOFIBRATE (MICRONIZED) ANDA #210705 |
SUPPL-14 |
FENOFIBRATE |
AJANTA PHARMA LTD |
Labeling |
Approval |
06/03/2021 |
FENOFIBRATE (MICRONIZED) ANDA #210782 |
SUPPL-3 |
FENOFIBRATE |
TORRENT |
Labeling |
Approval |
06/03/2021 |
REYVOW NDA #211280 |
SUPPL-5 |
LASMIDITAN SUCCINATE |
ELI LILLY AND CO |
Labeling |
Approval |
06/03/2021 |
THEOPHYLLINE ANDA #212184 |
ORIG-1 |
THEOPHYLLINE |
GLENMARK PHARMS LTD |
|
Approval |
06/03/2021 |
ICATIBANT ACETATE ANDA #212446 |
SUPPL-1 |
ICATIBANT ACETATE |
CIPLA |
Labeling |
Approval |
06/03/2021 |
FENOFIBRATE ANDA #213252 |
SUPPL-3 |
FENOFIBRATE |
ALEMBIC |
Labeling |
Approval |
06/03/2021 |
FENOFIBRATE (MICRONIZED) ANDA #213842 |
SUPPL-1 |
FENOFIBRATE |
ALEMBIC |
Labeling |
Approval |
06/03/2021 |
FENOFIBRATE ANDA #213864 |
SUPPL-6 |
FENOFIBRATE |
MANKIND PHARMA |
Labeling |
Approval |
06/03/2021 |
IBRUTINIB ANDA #214498 |
ORIG-1 |
IBRUTINIB |
ALVOGEN INC |
|
Tentative Approval |
06/04/2021 |
VANCOMYCIN HYDROCHLORIDE ANDA #065397 |
SUPPL-32 |
VANCOMYCIN HYDROCHLORIDE |
MYLAN LABS LTD |
Labeling |
Approval |
06/04/2021 |
VANCOMYCIN HYDROCHLORIDE ANDA #065432 |
SUPPL-28 |
VANCOMYCIN HYDROCHLORIDE |
MYLAN LABS LTD |
Labeling |
Approval |
06/04/2021 |
IRBESARTAN AND HYDROCHLOROTHIAZIDE ANDA #077369 |
SUPPL-10 |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TEVA |
Labeling |
Approval |
06/04/2021 |
IRBESARTAN AND HYDROCHLOROTHIAZIDE ANDA #077369 |
SUPPL-13 |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TEVA |
Labeling |
Approval |
06/04/2021 |
IRBESARTAN AND HYDROCHLOROTHIAZIDE ANDA #077369 |
SUPPL-17 |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TEVA |
Labeling |
Approval |
06/04/2021 |
IRBESARTAN AND HYDROCHLOROTHIAZIDE ANDA #077369 |
SUPPL-19 |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TEVA |
Labeling |
Approval |
06/04/2021 |
IRBESARTAN AND HYDROCHLOROTHIAZIDE ANDA #077446 |
SUPPL-11 |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
SANDOZ |
Labeling |
Approval |
06/04/2021 |
IRBESARTAN AND HYDROCHLOROTHIAZIDE ANDA #077446 |
SUPPL-12 |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
SANDOZ |
Labeling |
Approval |
06/04/2021 |
METHOTREXATE SODIUM ANDA #081235 |
SUPPL-30 |
METHOTREXATE SODIUM |
MYLAN |
Labeling |
Approval |
06/04/2021 |
IRBESARTAN AND HYDROCHLOROTHIAZIDE ANDA #090351 |
SUPPL-10 |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
HIKMA |
Labeling |
Approval |
06/04/2021 |
IRBESARTAN AND HYDROCHLOROTHIAZIDE ANDA #090351 |
SUPPL-11 |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
HIKMA |
Labeling |
Approval |
06/04/2021 |
IRBESARTAN AND HYDROCHLOROTHIAZIDE ANDA #091370 |
SUPPL-23 |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
ALEMBIC |
Labeling |
Approval |
06/04/2021 |
IRBESARTAN AND HYDROCHLOROTHIAZIDE ANDA #091370 |
SUPPL-26 |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
ALEMBIC |
Labeling |
Approval |
06/04/2021 |
LOPINAVIR AND RITONAVIR ANDA #091677 |
ORIG-1 |
LOPINAVIR; RITONAVIR |
HETERO LABS LTD III |
|
Approval |
06/04/2021 |
IRBESARTAN AND HYDROCHLOROTHIAZIDE ANDA #202414 |
SUPPL-36 |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
MACLEODS PHARMS LTD |
Labeling |
Approval |
06/04/2021 |
IRBESARTAN AND HYDROCHLOROTHIAZIDE ANDA #202414 |
SUPPL-43 |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
MACLEODS PHARMS LTD |
Labeling |
Approval |
06/04/2021 |
IRBESARTAN; HYDROCHLOROTHIAZIDE ANDA #202414 |
SUPPL-36 |
IRBESARTAN: HYDROCHLOROTHIAZIDE |
MACLEODS PHARMS LTD |
Labeling |
Approval |
06/04/2021 |
IRBESARTAN; HYDROCHLOROTHIAZIDE ANDA #202414 |
SUPPL-43 |
IRBESARTAN: HYDROCHLOROTHIAZIDE |
MACLEODS PHARMS LTD |
Labeling |
Approval |
06/04/2021 |
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE ANDA #204131 |
ORIG-1 |
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE |
CHARTWELL RX |
|
Approval |
06/04/2021 |
VALGANCICLOVIR HYDROCHLORIDE ANDA #212234 |
SUPPL-7 |
VALGANCICLOVIR HYDROCHLORIDE |
AJANTA PHARMA LTD |
Labeling |
Approval |
06/04/2021 |
VALGANCICLOVIR HYDROCHLORIDE ANDA #212234 |
SUPPL-9 |
VALGANCICLOVIR HYDROCHLORIDE |
AJANTA PHARMA LTD |
Labeling |
Approval |
06/04/2021 |
TRANEXAMIC ACID ANDA #212360 |
SUPPL-4 |
TRANEXAMIC ACID |
CAPLIN |
Labeling |
Approval |
06/04/2021 |
TACROLIMUS ANDA #213112 |
SUPPL-1 |
TACROLIMUS |
CONCORD BIOTECH LTD |
Labeling |
Approval |
06/04/2021 |
PANTOPRAZOLE SODIUM ANDA #213725 |
SUPPL-1 |
PANTOPRAZOLE SODIUM |
SUN PHARM |
Labeling |
Approval |
06/04/2021 |
TEMBEXA NDA #214460 |
ORIG-1 |
BRINCIDOFOVIR |
EMERGENT BIODEFENSE |
Type 2 - New Active Ingredient |
Approval |
06/04/2021 |
TEMBEXA NDA #214461 |
ORIG-1 |
BRINCIDOFOVIR |
EMERGENT BIODEFENSE |
Type 2 - New Active Ingredient |
Approval |
06/04/2021 |
WEGOVY NDA #215256 |
ORIG-1 |
SEMAGLUTIDE |
NOVO |
Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated |
Approval |
06/07/2021 |
HEPARIN SODIUM NDA #017029 |
SUPPL-159 |
HEPARIN SODIUM |
FRESENIUS KABI USA |
Labeling |
Approval |
06/07/2021 |
HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% NDA #017029 |
SUPPL-159 |
HEPARIN SODIUM |
FRESENIUS KABI USA |
Labeling |
Approval |
06/07/2021 |
HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% NDA #017029 |
SUPPL-159 |
HEPARIN SODIUM |
FRESENIUS KABI USA |
Labeling |
Approval |
06/07/2021 |
HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% NDA #017029 |
SUPPL-159 |
HEPARIN SODIUM |
FRESENIUS KABI USA |
Labeling |
Approval |
06/07/2021 |
HEPARIN SODIUM IN PLASTIC CONTAINER NDA #017029 |
SUPPL-159 |
HEPARIN SODIUM |
FRESENIUS KABI USA |
Labeling |
Approval |
06/07/2021 |
HEPARIN SODIUM PRESERVATIVE FREE NDA #017029 |
SUPPL-159 |
HEPARIN SODIUM |
FRESENIUS KABI USA |
Labeling |
Approval |
06/07/2021 |
HEPARIN SODIUM NDA #017651 |
SUPPL-69 |
HEPARIN SODIUM |
FRESENIUS KABI USA |
Labeling |
Approval |
06/07/2021 |
MEDROXYPROGESTERONE ACETATE ANDA #040159 |
SUPPL-29 |
MEDROXYPROGESTERONE ACETATE |
BARR |
Labeling |
Approval |
06/07/2021 |
METHOTREXATE SODIUM PRESERVATIVE FREE ANDA #040716 |
SUPPL-10 |
METHOTREXATE SODIUM |
ACCORD HLTHCARE |
Labeling |
Approval |
06/07/2021 |
METHOTREXATE SODIUM PRESERVATIVE FREE ANDA #040767 |
SUPPL-8 |
METHOTREXATE SODIUM |
ACCORD HLTHCARE |
Labeling |
Approval |
06/07/2021 |
METHOTREXATE SODIUM PRESERVATIVE FREE ANDA #040768 |
SUPPL-10 |
METHOTREXATE SODIUM |
ACCORD HLTHCARE |
Labeling |
Approval |
06/07/2021 |
PROPRANOLOL HYDROCHLORIDE ANDA #070213 |
SUPPL-36 |
PROPRANOLOL HYDROCHLORIDE |
MYLAN |
Labeling |
Approval |
06/07/2021 |
THIOTHIXENE ANDA #071093 |
SUPPL-30 |
THIOTHIXENE |
RISING PHARMA |
Labeling |
Approval |
06/07/2021 |
TRAZODONE HYDROCHLORIDE ANDA #073137 |
SUPPL-41 |
TRAZODONE HYDROCHLORIDE |
SUN PHARM INDUSTRIES |
Labeling |
Approval |
06/07/2021 |
TRAZODONE HYDROCHLORIDE ANDA #073137 |
SUPPL-42 |
TRAZODONE HYDROCHLORIDE |
SUN PHARM INDUSTRIES |
Labeling |
Approval |
06/07/2021 |
FLUOXETINE HYDROCHLORIDE ANDA #076990 |
SUPPL-22 |
FLUOXETINE HYDROCHLORIDE |
SUN PHARM INDS LTD |
Labeling |
Approval |
06/07/2021 |
FLUOXETINE HYDROCHLORIDE ANDA #076990 |
SUPPL-23 |
FLUOXETINE HYDROCHLORIDE |
SUN PHARM INDS LTD |
Labeling |
Approval |
06/07/2021 |
FLUOXETINE HYDROCHLORIDE ANDA #076990 |
SUPPL-26 |
FLUOXETINE HYDROCHLORIDE |
SUN PHARM INDS LTD |
Labeling |
Approval |
06/07/2021 |
FLUOXETINE HYDROCHLORIDE ANDA #076990 |
SUPPL-28 |
FLUOXETINE HYDROCHLORIDE |
SUN PHARM INDS LTD |
Labeling |
Approval |
06/07/2021 |
ONDANSETRON HYDROCHLORIDE ANDA #077544 |
SUPPL-2 |
ONDANSETRON HYDROCHLORIDE |
PLIVA HRVATSKA DOO |
Labeling |
Approval |
06/07/2021 |
ONDANSETRON HYDROCHLORIDE ANDA #077544 |
SUPPL-3 |
ONDANSETRON HYDROCHLORIDE |
PLIVA HRVATSKA DOO |
Labeling |
Approval |
06/07/2021 |
PENNSAID NDA #204623 |
SUPPL-10 |
DICLOFENAC SODIUM |
HORIZON |
Labeling |
Approval |
06/07/2021 |
DEXMEDETOMIDINE HYDROCHLORIDE NDA #206628 |
SUPPL-17 |
DEXMEDETOMIDINE HYDROCHLORIDE |
HQ SPCLT PHARMA |
Manufacturing (CMC) |
Approval |
06/07/2021 |
OSELTAMIVIR PHOSPHATE ANDA #210186 |
SUPPL-1 |
OSELTAMIVIR PHOSPHATE |
AMNEAL PHARMS NY |
Labeling |
Approval |
06/07/2021 |
OSELTAMIVIR PHOSPHATE ANDA #210186 |
SUPPL-5 |
OSELTAMIVIR PHOSPHATE |
AMNEAL PHARMS NY |
Labeling |
Approval |
06/07/2021 |
OSELTAMIVIR PHOSPHATE ANDA #210186 |
SUPPL-7 |
OSELTAMIVIR PHOSPHATE |
AMNEAL PHARMS NY |
Labeling |
Approval |
06/07/2021 |
BUSULFAN ANDA #210931 |
SUPPL-1 |
BUSULFAN |
SHILPA |
Labeling |
Approval |
06/07/2021 |
ARGATROBAN IN SODIUM CHLORIDE NDA #212035 |
ORIG-1 |
ARGATROBAN |
ACCORD HLTHCARE |
Type 5 - New Formulation or New Manufacturer |
Approval |
06/07/2021 |
DEXTROAMPHETAMINE SULFATE ANDA #212160 |
ORIG-1 |
DEXTROAMPHETAMINE SULFATE |
WINDER LABS LLC |
|
Approval |
06/07/2021 |
UDENYCA BLA #761039 |
SUPPL-10 |
PEGFILGRASTIM-CBQV |
COHERUS BIOSCIENCES INC |
|
Approval |
06/07/2021 |
ULTOMIRIS BLA #761108 |
SUPPL-12 |
RAVULIZUMAB-CWVZ |
ALEXION PHARM |
|
Approval |
06/07/2021 |
ADUHELM BLA #761178 |
ORIG-1 |
ADUCANUMAB-AVWA |
BIOGEN INC |
|
Approval |
06/08/2021 |
MIRENA NDA #021225 |
SUPPL-36 |
LEVONORGESTREL |
BAYER HLTHCARE |
Labeling |
Approval |
06/08/2021 |
LETAIRIS NDA #022081 |
SUPPL-43 |
AMBRISENTAN |
GILEAD |
REMS |
Approval |
06/08/2021 |
ATORVASTATIN CALCIUM ANDA #076477 |
SUPPL-10 |
ATORVASTATIN CALCIUM |
SUN PHARM INDS LTD |
Labeling |
Approval |
06/08/2021 |
ATORVASTATIN CALCIUM ANDA #076477 |
SUPPL-12 |
ATORVASTATIN CALCIUM |
SUN PHARM INDS LTD |
Labeling |
Approval |
06/08/2021 |
ATORVASTATIN CALCIUM ANDA #076477 |
SUPPL-15 |
ATORVASTATIN CALCIUM |
SUN PHARM INDS LTD |
Labeling |
Approval |
06/08/2021 |
ATORVASTATIN CALCIUM ANDA #076477 |
SUPPL-17 |
ATORVASTATIN CALCIUM |
SUN PHARM INDS LTD |
Labeling |
Approval |
06/08/2021 |
ATORVASTATIN CALCIUM ANDA #076477 |
SUPPL-23 |
ATORVASTATIN CALCIUM |
SUN PHARM INDS LTD |
Labeling |
Approval |
06/08/2021 |
ATORVASTATIN CALCIUM ANDA #076477 |
SUPPL-26 |
ATORVASTATIN CALCIUM |
SUN PHARM INDS LTD |
Labeling |
Approval |
06/08/2021 |
ATORVASTATIN CALCIUM ANDA #076477 |
SUPPL-27 |
ATORVASTATIN CALCIUM |
SUN PHARM INDS LTD |
Labeling |
Approval |
06/08/2021 |
LIGNOSPAN FORTE ANDA #088389 |
SUPPL-47 |
EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE |
DEPROCO |
Labeling |
Approval |
06/08/2021 |
LIGNOSPAN STANDARD ANDA #088390 |
SUPPL-55 |
EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE |
DEPROCO |
Labeling |
Approval |
06/08/2021 |
AMBRISENTAN ANDA #208252 |
SUPPL-4 |
AMBRISENTAN |
WATSON LABS INC |
REMS |
Approval |
06/08/2021 |
AMBRISENTAN ANDA #208354 |
SUPPL-4 |
AMBRISENTAN |
SIGMAPHARM LABS LLC |
REMS |
Approval |
06/08/2021 |
AMBRISENTAN ANDA #208441 |
SUPPL-3 |
AMBRISENTAN |
MYLAN |
REMS |
Approval |
06/08/2021 |
AMBRISENTAN ANDA #209509 |
SUPPL-4 |
AMBRISENTAN |
ENDO OPERATIONS |
REMS |
Approval |
06/08/2021 |
PERAMPANEL ANDA #209877 |
ORIG-1 |
PERAMPANEL |
ACCORD HLTHCARE |
|
Tentative Approval |
06/08/2021 |
AMBRISENTAN ANDA #210058 |
SUPPL-6 |
AMBRISENTAN |
ZYDUS PHARMS |
REMS |
Approval |
06/08/2021 |
AMBRISENTAN ANDA #210715 |
SUPPL-6 |
AMBRISENTAN |
CIPLA |
REMS |
Approval |
06/08/2021 |
AMBRISENTAN ANDA #210784 |
SUPPL-6 |
AMBRISENTAN |
SUN PHARM |
REMS |
Approval |
06/08/2021 |
TRIKAFTA (COPACKAGED) NDA #212273 |
SUPPL-4 |
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR |
VERTEX PHARMS INC |
Efficacy |
Approval |
06/09/2021 |
BETOPTIC S NDA #019845 |
SUPPL-30 |
BETAXOLOL HYDROCHLORIDE |
NOVARTIS |
Labeling |
Approval |
06/09/2021 |
METADATE ER ANDA #040306 |
SUPPL-18 |
METHYLPHENIDATE HYDROCHLORIDE |
LANNETT CO INC |
Labeling |
Approval |
06/09/2021 |
METADATE ER ANDA #040306 |
SUPPL-19 |
METHYLPHENIDATE HYDROCHLORIDE |
LANNETT CO INC |
Labeling |
Approval |
06/09/2021 |
METOPROLOL TARTRATE ANDA #074133 |
SUPPL-36 |
METOPROLOL TARTRATE |
HOSPIRA |
Labeling |
Approval |
06/09/2021 |
METOPROLOL TARTRATE ANDA #075160 |
SUPPL-21 |
METOPROLOL TARTRATE |
HOSPIRA |
Labeling |
Approval |
06/09/2021 |
MYALEPT BLA #125390 |
SUPPL-23 |
METRELEPTIN |
AMRYT |
|
Approval |
06/09/2021 |
FLUDEOXYGLUCOSE F18 ANDA #203246 |
SUPPL-4 |
FLUDEOXYGLUCOSE F-18 |
UNIV TX MD ANDERSON |
Labeling |
Approval |
06/09/2021 |
IZBA NDA #204822 |
SUPPL-2 |
TRAVOPROST |
NOVARTIS |
Labeling |
Approval |
06/10/2021 |
TREANDA NDA #022249 |
SUPPL-25 |
BENDAMUSTINE HYDROCHLORIDE |
CEPHALON |
Labeling |
Approval |
06/10/2021 |
LEVETIRACETAM ANDA #091557 |
SUPPL-9 |
LEVETIRACETAM |
ACTAVIS ELIZABETH |
Labeling |
Approval |
06/10/2021 |
LEVETIRACETAM ANDA #091557 |
SUPPL-10 |
LEVETIRACETAM |
ACTAVIS ELIZABETH |
Labeling |
Approval |
06/10/2021 |
LEVETIRACETAM ANDA #091557 |
SUPPL-11 |
LEVETIRACETAM |
ACTAVIS ELIZABETH |
Labeling |
Approval |
06/10/2021 |
EPCLUSA NDA #208341 |
SUPPL-17 |
SOFOSBUVIR; VELPATASVIR |
GILEAD SCIENCES INC |
Efficacy |
Approval |
06/10/2021 |
MAVYRET NDA #209394 |
SUPPL-13 |
GLECAPREVIR; PIBRENTASVIR |
ABBVIE |
Efficacy |
Approval |
06/10/2021 |
TOFACITINIB ANDA #209633 |
ORIG-1 |
TOFACITINIB |
BRECKENRIDGE PHARMS |
|
Tentative Approval |
06/10/2021 |
VENLAFAXINE HYDROCHLORIDE ANDA #214127 |
ORIG-1 |
VENLAFAXINE HYDROCHLORIDE |
ALKEM LABS LTD |
|
Approval |
06/10/2021 |
EPCLUSA NDA #214187 |
ORIG-1 |
SOFOSBUVIR; VELPATASVIR |
GILEAD SCIENCES INC |
Type 3 - New Dosage Form |
Approval |
06/10/2021 |
SODIUM PHENYLACETATE AND SODIUM BENZOATE NDA #215025 |
ORIG-1 |
SODIUM BENZOATE; SODIUM PHENYLACETATE |
MAIA PHARMS INC |
Type 5 - New Formulation or New Manufacturer |
Approval |
06/10/2021 |
MAVYRET NDA #215110 |
ORIG-1 |
GLECAPREVIR; PIBRENTASVIR |
ABBVIE |
Type 3 - New Dosage Form |
Approval |
06/10/2021 |
RITUXAN HYCELA BLA #761064 |
SUPPL-13 |
RITUXIMAB; HYALURONIDASE (HUMAN RECOMBINANT) |
GENENTECH INC |
|
Approval |
06/11/2021 |
HICON NDA #021305 |
SUPPL-47 |
SODIUM IODIDE I-131 |
JUBILANT |
Labeling |
Approval |
06/11/2021 |
SODIUM IODIDE I 131 NDA #021305 |
SUPPL-47 |
SODIUM IODIDE I-131 |
JUBILANT |
Labeling |
Approval |
06/11/2021 |
VANCOLED ANDA #062682 |
SUPPL-18 |
VANCOMYCIN HYDROCHLORIDE |
HIKMA |
Labeling |
Approval |
06/11/2021 |
VANCOLED ANDA #062682 |
SUPPL-19 |
VANCOMYCIN HYDROCHLORIDE |
HIKMA |
Labeling |
Approval |
06/11/2021 |
VANCOMYCIN HYDROCHLORIDE ANDA #062879 |
SUPPL-17 |
VANCOMYCIN HYDROCHLORIDE |
HIKMA |
Labeling |
Approval |
06/11/2021 |
VANCOMYCIN HYDROCHLORIDE ANDA #062879 |
SUPPL-18 |
VANCOMYCIN HYDROCHLORIDE |
HIKMA |
Labeling |
Approval |
06/11/2021 |
LEVETIRACETAM ANDA #091668 |
SUPPL-1 |
LEVETIRACETAM |
SANDOZ |
Labeling |
Approval |
06/11/2021 |
JARDIANCE NDA #204629 |
SUPPL-28 |
EMPAGLIFLOZIN |
BOEHRINGER INGELHEIM |
Labeling |
Approval |
06/11/2021 |
JARDIANCE NDA #204629 |
SUPPL-29 |
EMPAGLIFLOZIN |
BOEHRINGER INGELHEIM |
Labeling |
Approval |
06/11/2021 |
GLYXAMBI NDA #206073 |
SUPPL-27 |
EMPAGLIFLOZIN; LINAGLIPTIN |
BOEHRINGER INGELHEIM |
Labeling |
Approval |
06/11/2021 |
GLYXAMBI NDA #206073 |
SUPPL-30 |
EMPAGLIFLOZIN; LINAGLIPTIN |
BOEHRINGER INGELHEIM |
Labeling |
Approval |
06/11/2021 |
SYNJARDY NDA #206111 |
SUPPL-25 |
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
BOEHRINGER INGELHEIM |
Labeling |
Approval |
06/11/2021 |
SYNJARDY NDA #206111 |
SUPPL-26 |
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
BOEHRINGER INGELHEIM |
Labeling |
Approval |
06/11/2021 |
SYNJARDY XR NDA #208658 |
SUPPL-13 |
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
BOEHRINGER INGELHEIM |
Labeling |
Approval |
06/11/2021 |
SYNJARDY XR NDA #208658 |
SUPPL-15 |
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
BOEHRINGER INGELHEIM |
Labeling |
Approval |
06/11/2021 |
CARFILZOMIB ANDA #209330 |
ORIG-1 |
CARFILZOMIB |
BRECKENRIDGE |
|
Approval |
06/11/2021 |
CARFILZOMIB ANDA #209330 |
ORIG-2 |
CARFILZOMIB |
BRECKENRIDGE |
|
Tentative Approval |
06/11/2021 |
TEMAZEPAM ANDA #211542 |
SUPPL-1 |
TEMAZEPAM |
ALEMBIC |
Labeling |
Approval |
06/11/2021 |
TEMAZEPAM ANDA #211542 |
SUPPL-8 |
TEMAZEPAM |
ALEMBIC |
Labeling |
Approval |
06/11/2021 |
FULVESTRANT ANDA #211730 |
ORIG-1 |
FULVESTRANT |
APOTEX |
|
Approval |
06/11/2021 |
TRIJARDY XR NDA #212614 |
SUPPL-8 |
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE |
BOEHRINGER INGELHEIM |
Labeling |
Approval |
06/11/2021 |
TRIJARDY XR NDA #212614 |
SUPPL-10 |
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE |
BOEHRINGER INGELHEIM |
Labeling |
Approval |
06/11/2021 |
PRAMIPEXOLE DIHYDROCHLORIDE ANDA #212797 |
ORIG-1 |
PRAMIPEXOLE DIHYDROCHLORIDE |
XIAMEN LP PHARM CO |
|
Approval |
06/11/2021 |
LEVETIRACETAM ANDA #215069 |
ORIG-1 |
LEVETIRACETAM |
SCIEGEN PHARMS INC |
|
Approval |
06/14/2021 |
VALTREX NDA #020487 |
SUPPL-22 |
VALACYCLOVIR HYDROCHLORIDE |
GLAXOSMITHKLINE |
Labeling |
Approval |
06/14/2021 |
TREXALL ANDA #040385 |
SUPPL-21 |
METHOTREXATE SODIUM |
BARR |
Labeling |
Approval |
06/14/2021 |
DIAZEPAM ANDA #070313 |
SUPPL-24 |
DIAZEPAM |
HIKMA |
Labeling |
Approval |
06/14/2021 |
METHYLIN ER ANDA #075629 |
SUPPL-18 |
METHYLPHENIDATE HYDROCHLORIDE |
SPECGX LLC |
Labeling |
Approval |
06/14/2021 |
METHYLIN ER ANDA #075629 |
SUPPL-20 |
METHYLPHENIDATE HYDROCHLORIDE |
SPECGX LLC |
Labeling |
Approval |
06/14/2021 |
LIDOCAINE HYDROCHLORIDE ANDA #083158 |
SUPPL-122 |
LIDOCAINE HYDROCHLORIDE |
HOSPIRA |
Manufacturing (CMC) |
Approval |
06/14/2021 |
LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% ANDA #083158 |
SUPPL-122 |
LIDOCAINE HYDROCHLORIDE |
HOSPIRA |
Manufacturing (CMC) |
Approval |
06/14/2021 |
LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% ANDA #083158 |
SUPPL-122 |
LIDOCAINE HYDROCHLORIDE |
HOSPIRA |
Manufacturing (CMC) |
Approval |
06/14/2021 |
DRONABINOL ANDA #201463 |
SUPPL-6 |
DRONABINOL |
LANNETT CO INC |
Manufacturing (CMC) |
Approval |
06/14/2021 |
SODIUM BICARBONATE ANDA #202494 |
SUPPL-9 |
SODIUM BICARBONATE |
HOSPIRA |
Manufacturing (CMC) |
Approval |
06/14/2021 |
SODIUM BICARBONATE ANDA #202495 |
SUPPL-9 |
SODIUM BICARBONATE |
HOSPIRA |
Manufacturing (CMC) |
Approval |
06/14/2021 |
SODIUM BICARBONATE ANDA #202679 |
SUPPL-10 |
SODIUM BICARBONATE |
HOSPIRA |
Manufacturing (CMC) |
Approval |
06/14/2021 |
SOLOSEC NDA #209363 |
SUPPL-15 |
SECNIDAZOLE |
LUPIN |
Labeling |
Approval |
06/14/2021 |
AMINOCAPROIC ACID ANDA #212110 |
ORIG-1 |
AMINOCAPROIC ACID |
EDENBRIDGE PHARMS |
|
Approval |
06/14/2021 |
TESTOSTERONE ANDA #212882 |
ORIG-1 |
TESTOSTERONE |
ALEMBIC |
|
Approval |
06/14/2021 |
SOAANZ NDA #213218 |
ORIG-1 |
TORSEMIDE |
SARFE PHARMS |
Type 5 - New Formulation or New Manufacturer |
Approval |
06/14/2021 |
REZIPRES NDA #213536 |
ORIG-1 |
EPHEDRINE HYDROCHLORIDE |
DR REDDYS LABS SA |
Type 5 - New Formulation or New Manufacturer |
Approval |
06/14/2021 |
ETRAVIRINE ANDA #214196 |
ORIG-1 |
ETRAVIRINE |
AMNEAL |
|
Approval |
06/14/2021 |
EPHEDRINE SULFATE ANDA #214579 |
ORIG-1 |
EPHEDRINE SULFATE |
EUGIA PHARMA |
|
Approval |
06/14/2021 |
CLOBETASOL PROPIONATE ANDA #214895 |
ORIG-1 |
CLOBETASOL PROPIONATE |
AMNEAL |
|
Approval |
06/14/2021 |
DUPIXENT BLA #761055 |
SUPPL-16 |
DUPILUMAB |
REGENERON PHARMACEUTICALS |
|
Approval |
06/15/2021 |
LYSODREN NDA #016885 |
SUPPL-29 |
MITOTANE |
HRA PHARMA |
Labeling |
Approval |
06/15/2021 |
PROSCAR NDA #020180 |
SUPPL-47 |
FINASTERIDE |
ORGANON |
Labeling |
Approval |
06/15/2021 |
PROPECIA NDA #020788 |
SUPPL-28 |
FINASTERIDE |
ORGANON |
Labeling |
Approval |
06/15/2021 |
CYRAMZA BLA #125477 |
SUPPL-39 |
RAMUCIRUMAB |
ELI LILLY AND CO |
|
Approval |
06/15/2021 |
SAPROPTERIN DIHYDROCHLORIDE ANDA #207685 |
ORIG-1 |
SAPROPTERIN DIHYDROCHLORIDE |
DR REDDYS |
|
Approval |
06/15/2021 |
SILDENAFIL CITRATE ANDA #209302 |
SUPPL-3 |
SILDENAFIL CITRATE |
UMEDICA |
Manufacturing (CMC) |
Approval |
06/15/2021 |
SODIUM SULFATE; POTASSIUM SULFATE; MAGNESIUM SULFATE ANDA #212903 |
ORIG-1 |
SODIUM SULFATE;POTASSIUM SULFATE;MAGNESIUM SULFATE |
ANNORA PHARMA |
|
Tentative Approval |
06/15/2021 |
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA #214930 |
ORIG-1 |
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
ALKEM LABS LTD |
|
Approval |
06/16/2021 |
ZELAPAR NDA #021479 |
SUPPL-10 |
SELEGILINE HYDROCHLORIDE |
BAUSCH |
Labeling |
Approval |
06/16/2021 |
ALPRAZOLAM ANDA #074312 |
SUPPL-16 |
ALPRAZOLAM |
HIKMA |
Manufacturing (CMC) |
Approval |
06/16/2021 |
EFAVIRENZ ANDA #078509 |
ORIG-1 |
EFAVIRENZ |
STRIDES PHARMA |
|
Approval |
06/16/2021 |
IBANDRONATE SODIUM ANDA #204329 |
ORIG-1 |
IBANDRONATE SODIUM |
NANG KUANG PHARM CO |
|
Approval |
06/16/2021 |
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE ANDA #208740 |
ORIG-1 |
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE |
APOTEX |
|
Approval |
06/16/2021 |
IBUPROFEN ANDA #209179 |
SUPPL-1 |
IBUPROFEN |
AUROBINDO PHARMA LTD |
Manufacturing (CMC) |
Approval |
06/16/2021 |
TALZENNA NDA #211651 |
SUPPL-1 |
TALAZOPARIB TOSYLATE |
PFIZER |
Labeling |
Approval |
06/16/2021 |
MICAFUNGIN NDA #212156 |
ORIG-1 |
MICAFUNGIN SODIUM |
ENDO OPERATIONS |
Type 5 - New Formulation or New Manufacturer |
Approval |
06/16/2021 |
AYVAKIT NDA #212608 |
SUPPL-6 |
AVAPRITINIB |
BLUEPRINT MEDICINES |
Efficacy |
Approval |
06/16/2021 |
AYVAKIT NDA #212608 |
SUPPL-7 |
AVAPRITINIB |
BLUEPRINT MEDICINES |
Efficacy |
Approval |
06/16/2021 |
SEVELAMER HYDROCHLORIDE ANDA #213145 |
ORIG-1 |
SEVELAMER HYDROCHLORIDE |
LUPIN LTD |
|
Approval |
06/17/2021 |
ZOLADEX NDA #019726 |
SUPPL-66 |
GOSERELIN ACETATE |
TERSERA |
Labeling |
Approval |
06/17/2021 |
ZOLADEX NDA #020578 |
SUPPL-44 |
GOSERELIN ACETATE |
TERSERA |
Labeling |
Approval |
06/17/2021 |
BYETTA NDA #021773 |
SUPPL-44 |
EXENATIDE SYNTHETIC |
ASTRAZENECA AB |
Labeling |
Approval |
06/17/2021 |
TOVIAZ NDA #022030 |
SUPPL-19 |
FESOTERODINE FUMARATE |
PFIZER |
Efficacy |
Approval |
06/17/2021 |
RIFADIN NDA #050420 |
SUPPL-85 |
RIFAMPIN |
SANOFI AVENTIS US |
Labeling |
Approval |
06/17/2021 |
RIFADIN NDA #050627 |
SUPPL-28 |
RIFAMPIN |
SANOFI AVENTIS US |
Labeling |
Approval |
06/17/2021 |
RIFATER NDA #050705 |
SUPPL-19 |
ISONIAZID; PYRAZINAMIDE; RIFAMPIN |
SANOFI AVENTIS US |
Labeling |
Approval |
06/17/2021 |
OLANZAPINE ANDA #090881 |
SUPPL-8 |
OLANZAPINE |
SUN PHARM INDS |
Labeling |
Approval |
06/17/2021 |
OLANZAPINE ANDA #091038 |
SUPPL-7 |
OLANZAPINE |
SUN PHARM INDS |
Labeling |
Approval |
06/17/2021 |
INFLECTRA BLA #125544 |
SUPPL-18 |
INFLIXIMAB-DYYB |
CELLTRION INC |
|
Approval |
06/17/2021 |
NOXAFIL NDA #205053 |
SUPPL-11 |
POSACONAZOLE |
MERCK SHARP DOHME |
Efficacy |
Approval |
06/17/2021 |
NOXAFIL NDA #205596 |
SUPPL-13 |
POSACONAZOLE |
MERCK SHARP DOHME |
Efficacy |
Approval |
06/17/2021 |
CALCIUM GLUCONATE NDA #208418 |
SUPPL-7 |
CALCIUM GLUCONATE |
FRESENIUS KABI USA |
Labeling |
Approval |
06/17/2021 |
CALCIUM GLUCONATE IN SODIUM CHLORIDE NDA #208418 |
SUPPL-7 |
CALCIUM GLUCONATE |
FRESENIUS KABI USA |
Labeling |
Approval |
06/17/2021 |
PERAMPANEL ANDA #209538 |
ORIG-1 |
PERAMPANEL |
TARO PHARM INDS LTD |
|
Tentative Approval |
06/17/2021 |
SUBLOCADE NDA #209819 |
SUPPL-18 |
BUPRENORPHINE |
INDIVIOR |
Labeling |
Approval |
06/17/2021 |
DIMETHYL FUMARATE ANDA #210531 |
SUPPL-1 |
DIMETHYL FUMARATE |
MYLAN |
Manufacturing (CMC) |
Approval |
06/17/2021 |
LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE ANDA #211438 |
ORIG-1 |
LOPERAMIDE HYDROCHLORIDE; SIMETHICONE |
HETERO LABS LTD V |
|
Approval |
06/17/2021 |
FENTANYL CITRATE ANDA #212086 |
SUPPL-1 |
FENTANYL CITRATE |
FRESENIUS KABI USA |
Manufacturing (CMC) |
Approval |
06/17/2021 |
ASTEPRO ALLERGY NDA #213872 |
ORIG-1 |
AZELASTINE HYDROCHLORIDE |
BAYER HLTHCARE |
Type 8 - Partial Rx to OTC Switch |
Approval |
06/17/2021 |
CHILDREN'S ASTEPRO ALLERGY NDA #213872 |
ORIG-1 |
AZELASTINE HYDROCHLORIDE |
BAYER HLTHCARE |
Type 8 - Partial Rx to OTC Switch |
Approval |
06/17/2021 |
LEVORPHANOL TARTRATE ANDA #213906 |
ORIG-1 |
LEVORPHANOL TARTRATE |
SUN PHARM INDS INC |
|
Approval |
06/17/2021 |
QINLOCK NDA #213973 |
SUPPL-1 |
RIPRETINIB |
DECIPHERA PHARMS |
Labeling |
Approval |
06/21/2021 |
PRADAXA NDA #022512 |
SUPPL-41 |
DABIGATRAN ETEXILATE MESYLATE |
BOEHRINGER INGELHEIM |
Efficacy |
Approval |
06/21/2021 |
TOBRAMYCIN ANDA #064052 |
SUPPL-38 |
TOBRAMYCIN |
BAUSCH AND LOMB |
Labeling |
Approval |
06/21/2021 |
TOBRAMYCIN ANDA #064052 |
SUPPL-39 |
TOBRAMYCIN |
BAUSCH AND LOMB |
Labeling |
Approval |
06/21/2021 |
AMPICILLIN AND SULBACTAM ANDA #065240 |
SUPPL-23 |
AMPICILLIN SODIUM; SULBACTAM SODIUM |
SANDOZ |
Labeling |
Approval |
06/21/2021 |
AMPICILLIN AND SULBACTAM ANDA #065241 |
SUPPL-23 |
AMPICILLIN SODIUM; SULBACTAM SODIUM |
SANDOZ |
Labeling |
Approval |
06/21/2021 |
DOPAMINE HYDROCHLORIDE ANDA #070799 |
SUPPL-17 |
DOPAMINE HYDROCHLORIDE |
AM REGENT |
Labeling |
Approval |
06/21/2021 |
DOPAMINE HYDROCHLORIDE ANDA #070820 |
SUPPL-17 |
DOPAMINE HYDROCHLORIDE |
AM REGENT |
Labeling |
Approval |
06/21/2021 |
DOPAMINE HYDROCHLORIDE ANDA #070826 |
SUPPL-16 |
DOPAMINE HYDROCHLORIDE |
AM REGENT |
Labeling |
Approval |
06/21/2021 |
METHYLPHENIDATE HYDROCHLORIDE ANDA #204772 |
SUPPL-3 |
METHYLPHENIDATE HYDROCHLORIDE |
ALVOGEN |
Labeling |
Approval |
06/21/2021 |
METHYLPHENIDATE HYDROCHLORIDE ANDA #207488 |
SUPPL-7 |
METHYLPHENIDATE HYDROCHLORIDE |
ABHAI LLC |
Labeling |
Approval |
06/21/2021 |
DAPTOMYCIN NDA #210282 |
ORIG-1 |
DAPTOMYCIN |
HOSPIRA |
Type 5 - New Formulation or New Manufacturer |
Approval |
06/21/2021 |
EFINACONAZOLE ANDA #211969 |
ORIG-1 |
EFINACONAZOLE |
UMEDICA |
|
Approval |
06/21/2021 |
OXCARBAZEPINE ANDA #212428 |
ORIG-1 |
OXCARBAZEPINE |
CHARTWELL RX |
|
Approval |
06/21/2021 |
PRADAXA NDA #214358 |
ORIG-1 |
DABIGATRAN ETEXILATE MESYLATE |
BOEHRINGER INGELHEIM |
Type 3 - New Dosage Form |
Approval |
06/22/2021 |
AZOPT NDA #020816 |
SUPPL-23 |
BRINZOLAMIDE |
SANDOZ |
Labeling |
Approval |
06/22/2021 |
CARDURA XL NDA #021269 |
SUPPL-21 |
DOXAZOSIN MESYLATE |
VIATRIS |
Labeling |
Approval |
06/22/2021 |
CHLOROPROCAINE HYDROCHLORIDE ANDA #087446 |
SUPPL-19 |
CHLOROPROCAINE HYDROCHLORIDE |
HOSPIRA |
Labeling |
Approval |
06/22/2021 |
METRONIDAZOLE ANDA #090222 |
SUPPL-2 |
METRONIDAZOLE |
ALEMBIC |
Labeling |
Approval |
06/22/2021 |
LETROZOLE ANDA #090289 |
SUPPL-9 |
LETROZOLE |
TEVA PHARMS |
Manufacturing (CMC) |
Approval |
06/22/2021 |
VORICONAZOLE ANDA #090862 |
SUPPL-8 |
VORICONAZOLE |
SANDOZ INC |
Labeling |
Approval |
06/22/2021 |
VORICONAZOLE ANDA #090862 |
SUPPL-9 |
VORICONAZOLE |
SANDOZ INC |
Labeling |
Approval |
06/22/2021 |
VORICONAZOLE ANDA #090862 |
SUPPL-10 |
VORICONAZOLE |
SANDOZ INC |
Labeling |
Approval |
06/22/2021 |
VORICONAZOLE ANDA #090862 |
SUPPL-11 |
VORICONAZOLE |
SANDOZ INC |
Labeling |
Approval |
06/22/2021 |
VORICONAZOLE ANDA #090862 |
SUPPL-12 |
VORICONAZOLE |
SANDOZ INC |
Labeling |
Approval |
06/22/2021 |
VORICONAZOLE ANDA #090862 |
SUPPL-13 |
VORICONAZOLE |
SANDOZ INC |
Labeling |
Approval |
06/22/2021 |
FORMOTEROL FUMARATE ANDA #091141 |
ORIG-1 |
FORMOTEROL FUMARATE |
TEVA PHARMS USA INC |
|
Approval |
06/22/2021 |
HEMANGEOL NDA #205410 |
SUPPL-6 |
PROPRANOLOL HYDROCHLORIDE |
PIERRE FABRE |
Labeling |
Approval |
06/22/2021 |
METHYLPHENIDATE HYDROCHLORIDE ANDA #205756 |
SUPPL-2 |
METHYLPHENIDATE HYDROCHLORIDE |
RISING PHARMA |
Labeling |
Approval |
06/22/2021 |
ARFORMOTEROL TARTRATE ANDA #207306 |
ORIG-1 |
ARFORMOTEROL TARTRATE |
CIPLA |
|
Approval |
06/22/2021 |
NETSPOT NDA #208547 |
SUPPL-20 |
GALLIUM DOTATATE GA-68 |
AAA USA INC |
Labeling |
Approval |
06/22/2021 |
NETSPOT NDA #208547 |
SUPPL-22 |
GALLIUM DOTATATE GA-68 |
AAA USA INC |
Labeling |
Approval |
06/22/2021 |
BIJUVA NDA #210132 |
SUPPL-1 |
ESTRADIOL; PROGESTERONE |
MAYNE PHARMA |
Labeling |
Approval |
06/22/2021 |
BIJUVA NDA #210132 |
SUPPL-3 |
ESTRADIOL; PROGESTERONE |
MAYNE PHARMA |
Labeling |
Approval |
06/22/2021 |
MEDROXYPROGESTERONE ACETATE ANDA #210760 |
SUPPL-7 |
MEDROXYPROGESTERONE ACETATE |
SUN PHARM |
Labeling |
Approval |
06/22/2021 |
MEDROXYPROGESTERONE ACETATE ANDA #210760 |
SUPPL-8 |
MEDROXYPROGESTERONE ACETATE |
SUN PHARM |
Labeling |
Approval |
06/22/2021 |
MEDROXYPROGESTERONE ACETATE ANDA #210761 |
SUPPL-8 |
MEDROXYPROGESTERONE ACETATE |
SUN PHARM |
Labeling |
Approval |
06/22/2021 |
MEDROXYPROGESTERONE ACETATE ANDA #210761 |
SUPPL-9 |
MEDROXYPROGESTERONE ACETATE |
SUN PHARM |
Labeling |
Approval |
06/22/2021 |
NINTEDANIB ANDA #212555 |
ORIG-1 |
NINTEDANIB ESYLATE |
GLENMARK PHARMS LTD |
|
Tentative Approval |
06/22/2021 |
ARFORMOTEROL TARTRATE ANDA #213132 |
ORIG-1 |
ARFORMOTEROL TARTRATE |
GLENMARK PHARMS LTD |
|
Approval |
06/22/2021 |
ARFORMOTEROL TARTRATE ANDA #213762 |
ORIG-1 |
ARFORMOTEROL TARTRATE |
SLATE RUN PHARMA |
|
Approval |
06/23/2021 |
CARDURA NDA #019668 |
SUPPL-32 |
DOXAZOSIN MESYLATE |
VIATRIS |
Labeling |
Approval |
06/23/2021 |
OLOPATADINE HYDROCHLORIDE ANDA #204532 |
SUPPL-4 |
OLOPATADINE HYDROCHLORIDE |
SCIEGEN PHARMS INC |
Labeling |
Approval |
06/23/2021 |
OLOPATADINE HYDROCHLORIDE ANDA #204723 |
SUPPL-3 |
OLOPATADINE HYDROCHLORIDE |
SCIEGEN PHARMS INC |
Labeling |
Approval |
06/23/2021 |
ACETAMINOPHEN NDA #204767 |
SUPPL-7 |
ACETAMINOPHEN |
FRESENIUS KABI USA |
Labeling |
Approval |
06/23/2021 |
EPINEPHRINE NDA #205029 |
SUPPL-8 |
EPINEPHRINE |
BPI LABS |
Labeling |
Approval |
06/23/2021 |
DIAZEPAM ANDA #210363 |
SUPPL-5 |
DIAZEPAM |
BELOTECA |
Labeling |
Approval |
06/23/2021 |
DIAZEPAM ANDA #210363 |
SUPPL-6 |
DIAZEPAM |
BELOTECA |
Labeling |
Approval |
06/23/2021 |
XYWAV NDA #212690 |
SUPPL-5 |
CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE |
JAZZ |
Labeling |
Approval |
06/23/2021 |
VERKAZIA NDA #214965 |
ORIG-1 |
CYCLOSPORINE |
HARROW EYE |
Type 5 - New Formulation or New Manufacturer |
Approval |
06/24/2021 |
ELLA NDA #022474 |
SUPPL-11 |
ULIPRISTAL ACETATE |
LAB HRA PHARMA |
Efficacy |
Approval |
06/24/2021 |
TOBREX ANDA #062535 |
SUPPL-31 |
TOBRAMYCIN |
SANDOZ |
Labeling |
Approval |
06/24/2021 |
TOBREX ANDA #062535 |
SUPPL-33 |
TOBRAMYCIN |
SANDOZ |
Labeling |
Approval |
06/24/2021 |
GLYBURIDE AND METFORMIN HYDROCHLORIDE ANDA #076345 |
SUPPL-34 |
GLYBURIDE; METFORMIN HYDROCHLORIDE |
IMPAX LABS INC |
Labeling |
Approval |
06/24/2021 |
GLYBURIDE AND METFORMIN HYDROCHLORIDE ANDA #076345 |
SUPPL-36 |
GLYBURIDE; METFORMIN HYDROCHLORIDE |
IMPAX LABS INC |
Labeling |
Approval |
06/24/2021 |
GLYBURIDE AND METFORMIN HYDROCHLORIDE ANDA #076821 |
SUPPL-4 |
GLYBURIDE; METFORMIN HYDROCHLORIDE |
TEVA |
Labeling |
Approval |
06/24/2021 |
GLYBURIDE AND METFORMIN HYDROCHLORIDE ANDA #076821 |
SUPPL-5 |
GLYBURIDE; METFORMIN HYDROCHLORIDE |
TEVA |
Labeling |
Approval |
06/24/2021 |
TRANEXAMIC ACID ANDA #091596 |
SUPPL-5 |
TRANEXAMIC ACID |
FRESENIUS KABI USA |
Labeling |
Approval |
06/24/2021 |
TRANEXAMIC ACID ANDA #206713 |
SUPPL-4 |
TRANEXAMIC ACID |
MICRO LABS |
Labeling |
Approval |
06/24/2021 |
AUSTEDO NDA #208082 |
SUPPL-9 |
DEUTETRABENAZINE |
TEVA BRANDED PHARM |
Efficacy |
Approval |
06/24/2021 |
TRANEXAMIC ACID ANDA #208840 |
SUPPL-2 |
TRANEXAMIC ACID |
AMNEAL PHARMS CO |
Labeling |
Approval |
06/24/2021 |
TRANEXAMIC ACID ANDA #208840 |
SUPPL-4 |
TRANEXAMIC ACID |
AMNEAL PHARMS CO |
Labeling |
Approval |
06/24/2021 |
ZURAGARD NDA #210872 |
SUPPL-1 |
ISOPROPYL ALCOHOL |
ZUREX PHARMA |
Efficacy |
Approval |
06/24/2021 |
HEMADY NDA #211379 |
SUPPL-3 |
DEXAMETHASONE |
DEXCEL |
Labeling |
Approval |
06/25/2021 |
ROWASA NDA #019618 |
SUPPL-27 |
MESALAMINE |
MYLAN SPECIALITY LP |
Labeling |
Approval |
06/25/2021 |
SFROWASA NDA #019618 |
SUPPL-27 |
MESALAMINE |
MYLAN SPECIALITY LP |
Labeling |
Approval |
06/25/2021 |
DIPENTUM NDA #019715 |
SUPPL-29 |
OLSALAZINE SODIUM |
MYLAN SPCLT VIATRIS |
Labeling |
Approval |
06/25/2021 |
CONCERTA NDA #021121 |
SUPPL-44 |
METHYLPHENIDATE HYDROCHLORIDE |
JANSSEN PHARMS |
Labeling |
Approval |
06/25/2021 |
METADATE CD NDA #021259 |
SUPPL-32 |
METHYLPHENIDATE HYDROCHLORIDE |
AYTU BIOPHARMA |
Labeling |
Approval |
06/25/2021 |
METHYLIN NDA #021419 |
SUPPL-20 |
METHYLPHENIDATE HYDROCHLORIDE |
SPECGX LLC |
Labeling |
Approval |
06/25/2021 |
METHYLIN NDA #021475 |
SUPPL-11 |
METHYLPHENIDATE HYDROCHLORIDE |
SPECGX LLC |
Labeling |
Approval |
06/25/2021 |
DAYTRANA NDA #021514 |
SUPPL-32 |
METHYLPHENIDATE |
NOVEN PHARMS INC |
Labeling |
Approval |
06/25/2021 |
BRIDION NDA #022225 |
SUPPL-8 |
SUGAMMADEX SODIUM |
MSD SUB MERCK |
Efficacy |
Approval |
06/25/2021 |
METADATE ER ANDA #040306 |
SUPPL-20 |
METHYLPHENIDATE HYDROCHLORIDE |
LANNETT CO INC |
Labeling |
Approval |
06/25/2021 |
SUFENTANIL CITRATE ANDA #074534 |
SUPPL-14 |
SUFENTANIL CITRATE |
HOSPIRA |
Labeling |
Approval |
06/25/2021 |
SUFENTANIL CITRATE ANDA #074534 |
SUPPL-15 |
SUFENTANIL CITRATE |
HOSPIRA |
Labeling |
Approval |
06/25/2021 |
METHYLPHENIDATE HYDROCHLORIDE ANDA #075450 |
SUPPL-8 |
METHYLPHENIDATE HYDROCHLORIDE |
HERITAGE PHARMA |
Labeling |
Approval |
06/25/2021 |
METHYLIN ER ANDA #075629 |
SUPPL-23 |
METHYLPHENIDATE HYDROCHLORIDE |
SPECGX LLC |
Labeling |
Approval |
06/25/2021 |
METADATE ER ANDA #089601 |
SUPPL-36 |
METHYLPHENIDATE HYDROCHLORIDE |
LANNETT CO INC |
Labeling |
Approval |
06/25/2021 |
METFORMIN HYDROCHLORIDE ANDA #090295 |
SUPPL-2 |
METFORMIN HYDROCHLORIDE |
MARKSANS PHARMA |
Labeling |
Approval |
06/25/2021 |
METFORMIN HYDROCHLORIDE ANDA #090295 |
SUPPL-3 |
METFORMIN HYDROCHLORIDE |
MARKSANS PHARMA |
Labeling |
Approval |
06/25/2021 |
TEMOZOLOMIDE ANDA #201742 |
SUPPL-13 |
TEMOZOLOMIDE |
SUN PHARM |
Labeling |
Approval |
06/25/2021 |
TEMOZOLOMIDE ANDA #201742 |
SUPPL-16 |
TEMOZOLOMIDE |
SUN PHARM |
Labeling |
Approval |
06/25/2021 |
QUILLIVANT XR NDA #202100 |
SUPPL-18 |
METHYLPHENIDATE HYDROCHLORIDE |
NEXTWAVE |
Labeling |
Approval |
06/25/2021 |
IBUPROFEN ANDA #202413 |
SUPPL-16 |
IBUPROFEN |
SHANDONG XINHUA |
Labeling |
Approval |
06/25/2021 |
IBUPROFEN ANDA #202413 |
SUPPL-17 |
IBUPROFEN |
SHANDONG XINHUA |
Labeling |
Approval |
06/25/2021 |
METFORMIN HYDROCHLORIDE ANDA #203832 |
SUPPL-3 |
METFORMIN HYDROCHLORIDE |
NOSTRUM LABS INC |
Labeling |
Approval |
06/25/2021 |
METFORMIN HYDROCHLORIDE ANDA #203832 |
SUPPL-4 |
METFORMIN HYDROCHLORIDE |
NOSTRUM LABS INC |
Labeling |
Approval |
06/25/2021 |
METHYLPHENIDATE HYDROCHLORIDE ANDA #204115 |
SUPPL-5 |
METHYLPHENIDATE HYDROCHLORIDE |
NOVEL LABS INC |
Labeling |
Approval |
06/25/2021 |
DECITABINE ANDA #204607 |
SUPPL-5 |
DECITABINE |
PHARMASCIENCE INC |
Labeling |
Approval |
06/25/2021 |
METHYLPHENIDATE HYDROCHLORIDE ANDA #204954 |
SUPPL-3 |
METHYLPHENIDATE HYDROCHLORIDE |
NOSTRUM LABS INC |
Labeling |
Approval |
06/25/2021 |
COTEMPLA XR-ODT NDA #205489 |
SUPPL-7 |
METHYLPHENIDATE |
NEOS THERAPS INC |
Labeling |
Approval |
06/25/2021 |
METHYLPHENIDATE HYDROCHLORIDE ANDA #205756 |
SUPPL-7 |
METHYLPHENIDATE HYDROCHLORIDE |
RISING PHARMA |
Labeling |
Approval |
06/25/2021 |
APTENSIO XR NDA #205831 |
SUPPL-6 |
METHYLPHENIDATE HYDROCHLORIDE |
RHODES PHARMS |
Labeling |
Approval |
06/25/2021 |
GEMCITABINE HYDROCHLORIDE ANDA #206617 |
ORIG-1 |
GEMCITABINE HYDROCHLORIDE |
HIKMA INTL PHARMS |
|
Approval |
06/25/2021 |
METHYLPHENIDATE HYDROCHLORIDE ANDA #207488 |
SUPPL-8 |
METHYLPHENIDATE HYDROCHLORIDE |
ABHAI LLC |
Labeling |
Approval |
06/25/2021 |
QUILLICHEW ER NDA #207960 |
SUPPL-12 |
METHYLPHENIDATE HYDROCHLORIDE |
NEXTWAVE PHARMS |
Labeling |
Approval |
06/25/2021 |
JORNAY PM NDA #209311 |
SUPPL-8 |
METHYLPHENIDATE HYDROCHLORIDE |
IRONSHORE PHARMS |
Labeling |
Approval |
06/25/2021 |
DEXMETHYLPHENIDATE HYDROCHLORIDE ANDA #209468 |
SUPPL-3 |
DEXMETHYLPHENIDATE HYDROCHLORIDE |
LANNETT CO INC |
Labeling |
Approval |
06/25/2021 |
CAROSPIR NDA #209478 |
SUPPL-3 |
SPIRONOLACTONE |
CMP DEV LLC |
Labeling |
Approval |
06/25/2021 |
METHYLPHENIDATE HYDROCHLORIDE ANDA #210354 |
SUPPL-3 |
METHYLPHENIDATE HYDROCHLORIDE |
ASCENT PHARMS INC |
Labeling |
Approval |
06/25/2021 |
METHYLPHENIDATE HYDROCHLORIDE ANDA #210992 |
SUPPL-7 |
METHYLPHENIDATE HYDROCHLORIDE |
GRANULES |
Labeling |
Approval |
06/25/2021 |
GABAPENTIN ANDA #211330 |
SUPPL-1 |
GABAPENTIN |
PAI HOLDINGS PHARM |
Labeling |
Approval |
06/25/2021 |
GABAPENTIN ANDA #211330 |
SUPPL-2 |
GABAPENTIN |
PAI HOLDINGS PHARM |
Labeling |
Approval |
06/25/2021 |
NITROFURANTOIN ANDA #211935 |
ORIG-1 |
NITROFURANTOIN, MACROCRYSTALLINE |
ALEMBIC |
|
Approval |
06/25/2021 |
ADHANSIA XR NDA #212038 |
SUPPL-5 |
METHYLPHENIDATE HYDROCHLORIDE |
PURDUE PHARMA LP |
Labeling |
Approval |
06/25/2021 |
METHYLPHENIDATE HYDROCHLORIDE ANDA #212288 |
SUPPL-1 |
METHYLPHENIDATE HYDROCHLORIDE |
ALKEM LABS LTD |
Labeling |
Approval |
06/25/2021 |
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE NDA #212303 |
ORIG-1 |
DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE |
LUPIN PHARMS |
Type 4 - New Combination |
Tentative Approval |
06/25/2021 |
DOCETAXEL ANDA #214575 |
ORIG-1 |
DOCETAXEL |
EUGIA PHARMA |
|
Approval |
06/26/2021 |
RITALIN NDA #010187 |
SUPPL-93 |
METHYLPHENIDATE HYDROCHLORIDE |
SANDOZ |
Labeling |
Approval |
06/26/2021 |
FOCALIN NDA #021278 |
SUPPL-29 |
DEXMETHYLPHENIDATE HYDROCHLORIDE |
SANDOZ |
Labeling |
Approval |
06/26/2021 |
RITALIN LA NDA #021284 |
SUPPL-43 |
METHYLPHENIDATE HYDROCHLORIDE |
SANDOZ |
Labeling |
Approval |
06/26/2021 |
FOCALIN XR NDA #021802 |
SUPPL-39 |
DEXMETHYLPHENIDATE HYDROCHLORIDE |
SANDOZ |
Labeling |
Approval |
06/28/2021 |
ASTEPRO NDA #022203 |
SUPPL-18 |
AZELASTINE HYDROCHLORIDE |
MYLAN SPECIALITY LP |
Labeling |
Approval |
06/28/2021 |
AVEED NDA #022219 |
SUPPL-16 |
TESTOSTERONE UNDECANOATE |
ENDO OPERATIONS |
REMS |
Approval |
06/28/2021 |
KEYTRUDA BLA #125514 |
SUPPL-108 |
PEMBROLIZUMAB |
MERCK SHARP DOHME |
|
Approval |
06/28/2021 |
METHYLPHENIDATE HYDROCHLORIDE ANDA #204772 |
SUPPL-8 |
METHYLPHENIDATE HYDROCHLORIDE |
ALVOGEN |
Labeling |
Approval |
06/28/2021 |
METFORMIN HYDROCHLORIDE ANDA #205096 |
SUPPL-2 |
METFORMIN HYDROCHLORIDE |
CSPC OUYI |
Labeling |
Approval |
06/28/2021 |
METFORMIN HYDROCHLORIDE ANDA #205096 |
SUPPL-6 |
METFORMIN HYDROCHLORIDE |
CSPC OUYI |
Labeling |
Approval |
06/28/2021 |
NERLYNX NDA #208051 |
SUPPL-9 |
NERATINIB MALEATE |
PUMA BIOTECH |
Efficacy |
Approval |
06/28/2021 |
SYMTUZA NDA #210455 |
SUPPL-17 |
COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE |
JANSSEN PRODS |
Labeling |
Approval |
06/28/2021 |
ADHANSIA XR NDA #212038 |
SUPPL-2 |
METHYLPHENIDATE HYDROCHLORIDE |
PURDUE PHARMA LP |
Efficacy |
Approval |
06/28/2021 |
ERYTHROMYCIN ANDA #213628 |
ORIG-1 |
ERYTHROMYCIN |
CADILA PHARMS LTD |
|
Approval |
06/28/2021 |
CLINDAMYCIN PHOSPHATE ANDA #214526 |
ORIG-1 |
CLINDAMYCIN PHOSPHATE |
TARO |
|
Approval |
06/29/2021 |
SPRYCEL NDA #021986 |
SUPPL-25 |
DASATINIB |
BRISTOL MYERS SQUIBB |
Labeling |
Approval |
06/29/2021 |
PALONOSETRON HYDROCHLORIDE ANDA #202951 |
ORIG-1 |
PALONOSETRON HYDROCHLORIDE |
AVET LIFESCIENCES |
|
Approval |
06/29/2021 |
BUPRENORPHINE ANDA #204937 |
SUPPL-5 |
BUPRENORPHINE |
WATSON LABS TEVA |
Manufacturing (CMC) |
Approval |
06/29/2021 |
SYMJEPI NDA #207534 |
SUPPL-12 |
EPINEPHRINE |
ADAMIS PHARMS CORP |
Labeling |
Approval |
06/29/2021 |
EMFLAZA NDA #208684 |
SUPPL-5 |
DEFLAZACORT |
PTC THERAP |
Labeling |
Approval |
06/29/2021 |
EMFLAZA NDA #208685 |
SUPPL-5 |
DEFLAZACORT |
PTC THERAP |
Labeling |
Approval |
06/29/2021 |
ESLICARBAZEPINE ACETATE ANDA #211238 |
ORIG-1 |
ESLICARBAZEPINE ACETATE |
DR REDDYS |
|
Approval |
06/29/2021 |
DAPTOMYCIN ANDA #213623 |
ORIG-1 |
DAPTOMYCIN |
MEITHEAL |
|
Approval |
06/29/2021 |
DAPTOMYCIN ANDA #213786 |
ORIG-1 |
DAPTOMYCIN |
MEITHEAL |
|
Approval |
06/30/2021 |
TOPAMAX NDA #020505 |
SUPPL-63 |
TOPIRAMATE |
JANSSEN PHARMS |
Labeling |
Approval |
06/30/2021 |
TOPAMAX NDA #020844 |
SUPPL-54 |
TOPIRAMATE |
JANSSEN PHARMS |
Labeling |
Approval |
06/30/2021 |
TOPAMAX SPRINKLE NDA #020844 |
SUPPL-54 |
TOPIRAMATE |
JANSSEN PHARMS |
Labeling |
Approval |
06/30/2021 |
RITUXAN BLA #103705 |
SUPPL-5464 |
RITUXIMAB |
GENENTECH |
|
Approval |
06/30/2021 |
SOLOSEC NDA #209363 |
SUPPL-12 |
SECNIDAZOLE |
LUPIN |
Efficacy |
Approval |
06/30/2021 |
MULTRYS NDA #209376 |
SUPPL-2 |
CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE |
AM REGENT |
Manufacturing (CMC) |
Approval |
06/30/2021 |
TRALEMENT NDA #209376 |
SUPPL-2 |
CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE |
AM REGENT |
Manufacturing (CMC) |
Approval |
06/30/2021 |
ICOSAPENT ETHYL ANDA #209437 |
ORIG-1 |
ICOSAPENT ETHYL |
APOTEX |
|
Approval |
06/30/2021 |
APREMILAST ANDA #211782 |
ORIG-1 |
APREMILAST |
AMNEAL |
|
Approval |
06/30/2021 |
VENLAFAXINE HYDROCHLORIDE ANDA #214609 |
ORIG-1 |
VENLAFAXINE HYDROCHLORIDE |
APPCO |
|
Approval |
06/30/2021 |
RYLAZE BLA #761179 |
ORIG-1 |
ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN |
JAZZ PHARMS |
|
Approval |